Centene Corp (CNC):企業の財務・戦略的SWOT分析

◆英語タイトル:Centene Corp (CNC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDFS28142FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Centene Corp (CNC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. Centene provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts, and other health solutions through its specialty services companies. It provides a comprehensive range of managed healthcare products and services including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care (LTC), Foster Care, dual-eligible individuals (Duals), the Aged, blind or disabled program (ABD), Medicare and Health Insurance Marketplace. The company through its specialty services companies offers life and health management, behavioural health and specialty rehabilitation therapies, managed vision, long-term care programs, telehealth services and pharmacy benefits management to healthcare organizations, employer groups, state programs and other commercial organizations. The company along with its subsidiaries operates across the US. Centene is headquartered in St Louis, Missouri, the US.

The company reported premium revenue of US$100,055 million for the fiscal year ended December 2020 (FY2020), an increase of 48.4% over that in FY2019.

Centene Corp Key Recent Developments

Mar 01,2021: Centene Corporation Announces Executive Leadership Appointments
Feb 24,2021: Centene subsidiary ‘Ohana Health Plan selected to continue offering community care services to Hawaii Medicaid Members
Feb 04,2021: Oklahoma Complete Health appoints Clay Franklin as chief executive officer
Feb 01,2021: Centene selected for Statewide Medicaid Contract And Statewide Specialty Children’s plan contract in Oklahoma
Jan 14,2021: Reminder: Centene Corporation”s 2020 Fourth Quarter And Full Year Financial Results Conference Call

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Centene Corp – Key Facts
Centene Corp – Key Employees
Centene Corp – Key Employee Biographies
Centene Corp – Major Products and Services
Centene Corp – History
Centene Corp – Company Statement
Centene Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Centene Corp – Business Description
Business Segment: Managed Care
Overview
Performance
Key Stats
Business Segment: Specialty Services
Overview
Performance
Centene Corp – SWOT Analysis
SWOT Analysis – Overview
Centene Corp – Strengths
Centene Corp – Weaknesses
Centene Corp – Opportunities
Centene Corp – Threats
Centene Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Centene Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 01, 2021: Centene Corporation Announces Executive Leadership Appointments
Feb 24, 2021: Centene subsidiary ‘Ohana Health Plan selected to continue offering community care services to Hawaii Medicaid Members
Feb 04, 2021: Oklahoma Complete Health appoints Clay Franklin as chief executive officer
Feb 01, 2021: Centene selected for Statewide Medicaid Contract And Statewide Specialty Children’s plan contract in Oklahoma
Jan 14, 2021: Reminder: Centene Corporation”s 2020 Fourth Quarter And Full Year Financial Results Conference Call
Jan 04, 2021: Centene to buy health services provider Magellan Health in $2.2bn deal
Dec 18, 2020: Centene announces 2021 guidance
Dec 07, 2020: Centene appoints Brent Layton to Executive Vice President, Markets, Products, International, and Chief Business Development Officer
Oct 21, 2020: Meridian and Samsung donate smartphone devices to healthcare providers in Michigan
Oct 21, 2020: MHS Health Wisconsin and Samsung donate Smartphone devices to Healthcare Providers
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Centene Corp, Key Facts
Centene Corp, Key Employees
Centene Corp, Key Employee Biographies
Centene Corp, Major Products and Services
Centene Corp, History
Centene Corp, Subsidiaries
Centene Corp, Joint Venture
Centene Corp, Key Competitors
Centene Corp, Ratios based on current share price
Centene Corp, Annual Ratios
Centene Corp, Annual Ratios (Cont...1)
Centene Corp, Annual Ratios (Cont...2)
Centene Corp, Interim Ratios
Centene Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Centene Corp (CNC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Targa Resources Corp (TRGP):石油・ガス:M&Aディール及び事業提携情報
    Summary Targa Resources Corp (Targa) is an independent midstream oil and gas company that offers midstream services. The company’s business activities include gathering, compressing, treating, processing, and selling natural gas; storing, fractionating, treating, transporting, and selling natural ga …
  • J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM):企業の財務・戦略的SWOT分析
    Summary J B Chemicals and Pharmaceuticals Ltd (JBCPL) is a pharmaceutical company that manufactures and markets pharmaceutical formulations. The company provides products such as tablets, lozenges, injectables, creams, gels, ointments, liquid herbal syrups, capsules, and others. It provides contract …
  • Silence Therapeutics Plc (SLN)-製薬・医療分野:企業M&A・提携分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a research and development company that develops and delivers RNA interference therapeutics for the treatment of serious diseases. The company's pipeline products include Atu027 and Atu111. Its Atu027 is developed for …
  • Homology Medicines, Inc. (FIXX):製薬・医療:M&Aディール及び事業提携情報
    Summary Homology Medicines, Inc. (Homology Medicines) is a pre-clinical stage biopharmaceutical company engaged in translating gene editing and gene therapy into novel treatment for patients suffering from rare genetic diseases. It offers HMI-102 product, which is in clinical stage for the treatment …
  • Scholastic Corporation:企業の戦略・SWOT・財務分析
    Scholastic Corporation - Strategy, SWOT and Corporate Finance Report Summary Scholastic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Geron Corp (GERN)-製薬・医療分野:企業M&A・提携分析
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • PT Telekomunikasi Indonesia, Tbk:企業の戦略・SWOT・財務情報
    PT Telekomunikasi Indonesia, Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Telekomunikasi Indonesia, Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • PowerFilm, Inc.:企業の戦略的SWOT分析
    PowerFilm, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Orca Gold Inc (ORG):企業の財務・戦略的SWOT分析
    Summary Orca Gold Inc (Orca Gold), formerly Canaco Resources Inc, subsidiary of Pinetree Capital Ltd, is a gold exploration company. The company's activities include acquisition, exploration and development of mineral properties in North and West Africa. It holds interests in The Block 14 gold proje …
  • Immunodiagnostic Systems Holdings plc (IDH):医療機器:M&Aディール及び事業提携情報
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • WPP plc:企業の戦略・SWOT・財務分析
    WPP plc - Strategy, SWOT and Corporate Finance Report Summary WPP plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Coeur Mining Inc
    Coeur Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Coeur Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hey-Song Corporation:企業の戦略・SWOT・財務情報
    Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report Summary Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Royal Bank Of Scotland Group Plc
    The Royal Bank Of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Royal Bank Of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Xcel Energy Inc (XEL):企業の財務・戦略的SWOT分析
    Xcel Energy Inc (XEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cosumar SA:企業の戦略・SWOT・財務分析
    Cosumar SA - Strategy, SWOT and Corporate Finance Report Summary Cosumar SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cardiff University:製薬・医療:M&Aディール及び事業提携情報
    Summary Cardiff University is an educational institution that offers education and research services. The institute provides undergraduate courses, post graduate courses, international courses, accommodations and libraries. It conducts research in the areas of engineering and physical sciences, bio- …
  • Diamondback Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Diamondback Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Diamondback Energy Inc (Diamondback Energy) is an oil and gas company that offers exploration and development programs. The company acquires, develops, explores and exploits unconventional, on …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆